CN103316270B - Preparation method of powder of medicine for treating postnatal perineum mucosal lesion - Google Patents

Preparation method of powder of medicine for treating postnatal perineum mucosal lesion Download PDF

Info

Publication number
CN103316270B
CN103316270B CN201310267854.1A CN201310267854A CN103316270B CN 103316270 B CN103316270 B CN 103316270B CN 201310267854 A CN201310267854 A CN 201310267854A CN 103316270 B CN103316270 B CN 103316270B
Authority
CN
China
Prior art keywords
parts
powder
perineum
medicine
dry extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310267854.1A
Other languages
Chinese (zh)
Other versions
CN103316270A (en
Inventor
丁霄雁
姜春杰
Original Assignee
丁霄雁
姜春杰
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 丁霄雁, 姜春杰 filed Critical 丁霄雁
Priority to CN201310267854.1A priority Critical patent/CN103316270B/en
Publication of CN103316270A publication Critical patent/CN103316270A/en
Application granted granted Critical
Publication of CN103316270B publication Critical patent/CN103316270B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a preparation method of powder of a medicine for treating postnatal perineum mucosal lesion, which is used for solving the problems in treatment by use of a medicine for treating postnatal perineum mucosal lesion. The preparation method is characterized by comprising the following steps of: (1) performing reduced-pressure distillation on the coarse powder of cortex erythrinae, radix ranunculi ternati and radix ephedrae, and extracting volatile oil; (2) performing reduced-pressure decoction on gastrodia elata to obtain filtrate; (3) decocting trikeraia hookeri, alpinia japonica, herba taxilli, coking malt, coking medicated leaven, spina gleditsiae, peach gum and rhizoma anemones altaicae and the dregs obtained in the step (1) with water to obtain filtrate for later use; (4) combining the filtrates obtained by the steps (2) and (3), performing reduced-pressure concentration to obtain a dry extract, and grinding the dry extract to obtain dry extract powder; and (5) spraying the volatile oil obtained in the step (1) into the dry extract powder obtained in the step (4), mixing uniformly, screening by a 100-mesh sieve, and sub-packing to obtain the powder. Clinical experiments prove that the medicine for treating postnatal perineum mucosal lesion has the characteristics of good curative effect and high safety, and deserves clinical application and popularization.

Description

A kind of powder preparation method for the treatment of postpartum perineum mucosa infection medicine
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of powder preparation method for the treatment of postpartum perineum mucosa infection medicine.
Background technology
Puerperal uterus, cervix uteri, vagina, perineum can produce a series of change because hormonal readiness declines rapidly.For perineum, during childbirth, due to fetus extruding vagina collar extension.Usually cause perineum hyperemia, edema, or have laceration in various degree, fade away in after this 7 days.Meanwhile, perineal position also there will be pleat around to be reduced, and intravaginal mucosa is smooth, and mucosal defense power reduces the symptoms such as easy secondary pruritus vulvae, vaginal dryness.In general, at short notice, vaginal mucosa is not easy to return to pregravidic situation completely, and only after stopping is breast-feeded, menstrual onset, ovarian function is normal, and under functions of hormones, vaginal mucosa just recovers normal gradually.
Current is for symptom for postpartum perineum mucosa infection mostly, and as given 50% magnesium sulfate dressing to alleviate edema, 1:5000 potassium permanganate liquid rinses the soak of cooperation 0.2% metronidazole solution to protect from infection.But in fact, because the basic pathology of morbidity is: puerperal, estrogen level declined rapidly, caused the relative atrophy of vaginal wall, mucosa is thinning, and in epithelial cell, glycogen content reduces, and intravaginal Ph value rises, local resistance reduces, and pathogenic bacterium are easily invaded breeding and cause and inflammation.And magnesium sulfate, potassium permanganate liquid flushing liquor are also a kind of stimulations for mucosa, early stage myxedema problem can be solved, but unfavorable on the contrary to long-term prognosis.
And Chinese medicine perineum Wet-dressing agent is many, but be mostly for Women of Childbearing Age, many containing the medicine except noxious dampness such as Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, Rhizoma Smilacis Glabrae in prescription, and the cause of postpartum perineum mucosa infection mainly mucosa is thinning causes, the medicine external of above dispelling the damp pathogen with drugs of bitter in taste and cold in nature, then irritates nucous membrane more, causes aggravation.And said medicine bitter cold is unfavorable for postpartum recovery.
Summary of the invention
Technical assignment of the present invention is for above the deficiencies in the prior art, provides a kind of curative effect certainly and the powder of the little treatment postpartum perineum mucosa infection medicine of side effect.
The technical scheme that the present invention solves its technical problem is: a kind of powder for the treatment of postpartum perineum mucosa infection medicine, it is characterized in that being prepared from by the crude drug of following weight proportion: Cortex erythrinae 10 ~ 30 parts, Herba Chlorophyti Laxi 6 ~ 12 parts, go back 3 ~ 10 parts, bobbin, Alpinia japonica (Thunb.) Miq. 6 ~ 12 parts, Herba Taxilli 3 ~ 10 parts, Radix Ranunculi Ternati 6 ~ 12 parts, Fructus Hordei Germinatus (parched to brown) 6 ~ 12 parts, Massa Medicata Fermentata (parched to brown) 6 ~ 12 parts, Radix Ephedrae 6 ~ 12 parts, Spina Gleditsiae 1 ~ 5 part, gumshiraz 3 ~ 10 parts, Rhizoma Anemones Altaicae 10 ~ 25 parts.
Chinese medicine of the present invention can be prepared from by following method:
(1) by Cortex erythrinae, Radix Ranunculi Ternati, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Alpinia japonica (Thunb.) Miq., Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Spina Gleditsiae, gumshiraz, Rhizoma Anemones Altaicae and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, pulverizes to obtain dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
The pressure of the distilling under reduced pressure in above-mentioned steps (1) is 0.1Mpa.
The pressure that decompression in above-mentioned steps (2) decocts is 0.4Mpa.
The pressure of the concentrating under reduced pressure in above-mentioned steps (4) is 0.4Mpa.
Wherein said: Cortex erythrinae is bark or the root bark of pulse family Erythrinae Arborescentis Erythrina indica Lam..Nature and flavor are bitter, flat.Return liver, kidney channel.Merit can wind-damp dispelling, channels sootheing and network vessel quickening.Wind-damp dispelling, the meridian dredging, parasite killing.
Herba Chlorophyti Laxi is herb or the root of feverfew Prenanthes henryi Dunn Prenanthes henryi Dunn.Bitter in the mouth; Cold in nature.Merit can heat-clearing and toxic substances removing; Dissipating blood stasis stops blooding.
Also bobbin is the fruit of orchid Rhizoma Gastrodiae Gastrodia elata Bl..Sweet in the mouth; Cold in nature.Merit can tonify deficiency subduing the wind syndrome.Main dizzy; Pupil; Wind syndrome of head is had a headache; Weak breath consumption of essence; Early whitening of beard and hair.
Alpinia japonica (Thunb.) Miq., is Zingiberaceae Alpinia plants Alpinia japonica (Thunb.) Miq. Alpinia japonica Miq., is used as medicine with root stock.Nature and flavor are pungent, warm.Return lung, spleen, Liver Channel.Merit can dispelling wind and removing obstruction in the collateral, regulating QI to relieve pain.
Herba Taxilli, for Herba Taxilli is the dry stem and branch with leaf of Loranthaceae plant Herba Taxilli Taxillus chinensis (DC.) Danser.Nature and flavor bitter, sweet, flat.Return liver, kidney channel.Merit can invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit.
Radix Ranunculi Ternati is the dried root of ranunculaceae plant Seynuns Kugelann Ranunculus ternatus Thunb..Nature and flavor sweet, acrid, warm.Return liver, lung meridian.Merit can eliminating stagnation, detumescence.
Fructus Hordei Germinatus (parched to brown), for the mature fruit of grass Fructus Hordei Vulgaris Hordeum vulgare L. is through drying of germinateing, fries to burnt brown according to frying method, cooling, sieve dedust bits.Nature and flavor are sweet, flat.Return spleen, stomach warp.Merit can promote qi circulation digestion promoting, and spleen benefiting and stimulating the appetite, moves back newborn relieving distension.
Massa Medicata Fermentata (parched to brown), for the medicines such as Herba polygoni hydropiperis, Herba Artemisiae Annuae, Semen Armeniacae Amarum add flour or wheat bran mixed after, through the herbal leaven of fermentation, fry to burnt brown according to frying method.Nature and flavor sweet, acrid, warm.Enter spleen, stomach warp.Merit can invigorating the spleen and regulating the stomach, helps digestion in adjusting.
Radix Ephedrae is the dry root and rhizome of Ephedraceae plant plait Herba Ephedrae Ephedra sinica Stapf or epheday intermedia Ephedra intermedia Schrenk et C. A. Mey..Nature and flavor are sweet, flat.GUIXIN, lung meridian.Merit can hidroschesis.
Spina Gleditsiae is the dry Spina jujubae of leguminous plant Fructus Gleditsia Gleditsia sinensis Lam..Nature and flavor are pungent, temperature.Return liver, stomach warp.Merit can be subsided a swelling poison holding, evacuation of pus, parasite killing.
Gumshiraz is rosaceous plant Fructus Persicae Prunus persica (L.) Batsch, the resin that trunk flows out.Nature and flavor are bitter, flat.Merit can be invigorated blood circulation, and QI invigorating is quenched the thirst.
Rhizoma Anemones Altaicae, is Ranunculaceae thimbleweed anemone altaica Anemone altaica Mey., is used as medicine with root stock.Nature and flavor are pungent, temperature.Merit can causing resuscitation with aromatic drugs, reduces phlegm, calms the nerves.
Composition principle: postpartum perineum mucosa infection often reduces because of ovarioestrogen level, and vaginal wall mucosa is thinning, in epithelial cell, glycogen content reduces, and intravaginal Ph value rises, and local resistance reduces, and pathogenic bacterium are easily invaded breeding and cause and inflammation.Cardinal symptom is that vaginal secretions increases and pruritus vulvae, burning sensation.The colpitic suppository of current Chinese traditional treatment, Wet-dressing agent are many, but be mostly for Women of Childbearing Age, many containing the medicine except noxious dampness such as Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, Rhizoma Smilacis Glabrae in prescription, and the cause of postpartum perineum mucosa infection mainly mucosa is thinning causes, the medicine external of above dispelling the damp pathogen with drugs of bitter in taste and cold in nature, then irritates nucous membrane more, causes aggravation.The object of the invention is to avoid using dispelling the damp pathogen with drugs of bitter in taste and cold in nature medicine, and reduce from estrogen level, vaginal wall atrophy, mucosa this pathological change angle thinning is started with, and reaches the object of " treatment of disease must aim at its pathogenesis ".
Compared with prior art, the present invention has following characteristics:
1, prescription is unique, avoids using dispelling the damp pathogen with drugs of bitter in taste and cold in nature antipruritic agent: get Cortex erythrinae in side, go back bobbin for monarch, the Cortex erythrinae dosage recorded in " China's book on Chinese herbal medicine " is: " for oral administration: to decoct soup, 6-12g "; Inventor to test in proof heavy dose of Cortex erythrinae (10 ~ 30g) and can recover by specific promotion vaginal wall mucosa, and goes back bobbin and have similar plants estrogen action, but this act as two-ways regulation, can not produce the low differentiation of estrogen excessive stimulation reproductive system cell;
2, characteristic of the present invention is also balance and restriction: records Cortex erythrinae in 1. " must joining book on Chinese herbal medicine ": " insufficiency of blood heated person forbid ", but puerperal resembling often with deficiency of YIN-blood, and now use Cortex erythrinae, then have and fear its hematozemia and cause yin asthenia generating intrinsic heat to occur; Therefore add Herba Chlorophyti Laxi and go back bobbin, also bobbin merit can train base by tonify deficiency, and can prevent Cortex erythrinae from consuming cloudy blood and liver-wind stirring up internally, and Herba Chlorophyti Laxi bitter in the mouth is cold in nature, utilize on the one hand it coldly to prevent heated, its merit can dissipating blood stasis hemostasis on the other hand, has out entire merit in blood system, prevent Cortex erythrinae to wander away dynamic blood, also can not affect Cortex erythrinae works orderly effect simultaneously; 2. in we, the use of Rhizoma Anemones Altaicae is: a causing resuscitation with aromatic drugs and benefaction, two Yin Yang balancings, and to balance the bitter cold of our invasion by pathogenic cold medicine of a cold nature thing, inventor's clinical research finds that Rhizoma Anemones Altaicae is activated yang and do not consume the moon in addition, is suitable for using puerperal; In prescription of the present invention, the application characteristic of Rhizoma Anemones Altaicae is: measure larger (consumption in " Chinese Pharmacopoeia " is 1.5-6g), so too disperse for preventing, gets again Radix Ephedrae convergence assistant system;
3, supplementary drug thing is fewer but better: get Alpinia japonica (Thunb.) Miq. assistant in side and help Herba Chlorophyti Laxi, heat conduction is descending; Radix Ranunculi Ternati and Herba Chlorophyti Laxi are arranged in pairs or groups the effect of removing toxic substances, eliminating stagnation, pain relieving; Herba Taxilli assistant helps goes back bobbin vital base and primordial QI consolidating; Gumshiraz is invigorated blood circulation, and contributes to drag residence in mucomembranous surface, penetration enhancement;
4, inventor's clinical research finds, solid protection gastric qi contributes to the drug disease process control of postpartum perineum mucosa infection and recovery, so select Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown) spleen benefiting and stimulating the appetite;
5, Spina Gleditsiae is supplementary drug thing, record in " China book on Chinese herbal medicine " consumption be: " for oral administration: to decoct soup, 6 ~ 12g ", the present inventor's experimental study finds, gets low dose of Spina Gleditsiae decocting liquid and can improve in vitro vaginal mucosa cytoactive.
6, the homogeneous medicine multiple-effect of institute's thing of getting it filled in side, contributes to reducing medicament categories and consumption, does not increase local excitation;
7, medicine material consumption of the present invention is groped to sum up to draw through inventor in a large number, and each raw material dosage is for all to have good curative effect in following weight parts scope;
8, the fruit that bobbin is orchid Rhizoma Gastrodiae is gone back, compared with Rhizoma Gastrodiae, going back the Esterified Enzyme isozyme (esterase isoenzyme) that bobbin contains, may be that it plays the key of phytoestrogen effect, and inventor's experiment draws, it is higher that decompression goes back bobbin Esterified Enzyme isozyme content after decocting.
Detailed description of the invention
Below in conjunction with practical situation, the specific embodiment of the present invention is elaborated.
Embodiment 1, crude drug weight proportion: Cortex erythrinae 20g, Herba Chlorophyti Laxi 10g, go back bobbin 6g, Alpinia japonica (Thunb.) Miq. 10g, Herba Taxilli 6g, Radix Ranunculi Ternati 10g, Fructus Hordei Germinatus (parched to brown) 10g, Massa Medicata Fermentata (parched to brown) 10g, Radix Ephedrae 10g, Spina Gleditsiae 2g, gumshiraz 6g, Rhizoma Anemones Altaicae 20g.
The preparation method of embodiment 1 is: by Cortex erythrinae, Herba Chlorophyti Laxi, go back bobbin, Alpinia japonica (Thunb.) Miq., Herba Taxilli, Radix Ranunculi Ternati, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Radix Ephedrae, Spina Gleditsiae, gumshiraz, the decoction of Rhizoma Anemones Altaicae mixing and water adding, filtrate is got after 30 minutes, medicinal residues add water continue decoction get filtrate after 20 minutes, twice filtrate merges washout, once a day.
Embodiment 2, crude drug weight proportion: Cortex erythrinae 10 parts, Herba Chlorophyti Laxi 6 parts, go back 3 parts, bobbin, Alpinia japonica (Thunb.) Miq. 6 parts, Herba Taxilli 3 parts, Radix Ranunculi Ternati 6 parts, Fructus Hordei Germinatus (parched to brown) 6 parts, Massa Medicata Fermentata (parched to brown) 6 parts, Radix Ephedrae 6 parts, Spina Gleditsiae 1 part, gumshiraz 3 parts, Rhizoma Anemones Altaicae 10 parts.
Embodiment 3, crude drug weight proportion: Cortex erythrinae 20 parts, Herba Chlorophyti Laxi 10 parts, go back 6 parts, bobbin, Alpinia japonica (Thunb.) Miq. 10 parts, Herba Taxilli 6 parts, Radix Ranunculi Ternati 10 parts, Fructus Hordei Germinatus (parched to brown) 10 parts, Massa Medicata Fermentata (parched to brown) 10 parts, Radix Ephedrae 10 parts, Spina Gleditsiae 2 parts, gumshiraz 6 parts, Rhizoma Anemones Altaicae 20 parts.
Embodiment 4, crude drug weight proportion: Cortex erythrinae 30 parts, Herba Chlorophyti Laxi 12 parts, go back 10 parts, bobbin, Alpinia japonica (Thunb.) Miq. 12 parts, Herba Taxilli 10 parts, Radix Ranunculi Ternati 12 parts, Fructus Hordei Germinatus (parched to brown) 12 parts, Massa Medicata Fermentata (parched to brown) 12 parts, Radix Ephedrae 12 parts, Spina Gleditsiae 5 parts, gumshiraz 10 parts, Rhizoma Anemones Altaicae 25 parts.
The Chinese medicine of embodiment 2 ~ 4 can be prepared from by following method:
(1) by Cortex erythrinae, Radix Ranunculi Ternati, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Alpinia japonica (Thunb.) Miq., Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Spina Gleditsiae, gumshiraz, Rhizoma Anemones Altaicae and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, pulverizes to obtain dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
In prioritization scheme, the pressure of the distilling under reduced pressure in described step (1) is 0.1Mpa; The pressure that decompression in described step (2) decocts is 0.4Mpa; The pressure of the concentrating under reduced pressure in described step (4) is 0.4Mpa.
The efficient combination of said medicine, coordinates mutually, effectively reach the object for the treatment of postpartum perineum mucosa infection medicine, and side effect is less.The above results is clinical data sufficient proof, and interrelated data is as follows.
1 object and method.
1.1 object.
1 data and method.
1.1.1 case selection: in January, 2011 ~ 2013 are diagnosed as postpartum perineum mucosa infection 148 example year June, are full-term normal delivery primipara.Get rid of trichomonal vaginitis, monilial vaginitis, urine is cultivated negative.
1.1.2 diagnostic criteria: with reference to " obstetrics and gynecology " (the 5th edition), all cases is all clarified a diagnosis according to medical history, gynecologial examination.Symptom is perineum pruritus, xerosis vulae, the pale or flushing of vaginal mucosa or have little petechia, and vaginal health scoring <15 divides.
1.1.3 divide into groups: be divided into matched group 48 example, soak group 50 example and powder group 50 example.Compare in age, the state of an illness, the course of disease before three groups of patient treatments, no significant difference (P>0.05), has comparability.
1.2 method.
1.2.1 Therapeutic Method: matched group adopts 1:5000 potassium permanganate liquid to rinse the soak of cooperation 0.2% metronidazole solution, 1 time/d.Soak group with gained decoct soak in the embodiment of the present invention 1,1 time/d.Powder group is blown deposited with gained powder pudendum and intravaginal in the embodiment of the present invention 3,1 time/d.It within 7 days, is a course for the treatment of.
1.2.2 observation index: conventional inquiry medical history before and after medication, and according to vaginal health point system (VHS) scoring, determine that symptom improves situation.
1.2.3 criterion of therapeutical effect: with reference to " obstetrics and gynecology ", recovery from illness: clinical symptoms, sign disappear; Effective: clinical symptoms, sign turn for the better by and large; Effective: clinical symptoms, sign alleviate; Invalid: clinical symptoms, sign are unchanged.
1.2.4 statistical analysis: SPSS 16.0 carries out statistical analysis.Vaginal health scoring single index adopts nonparametric statistics.Measurement data t checks, enumeration data χ 2inspection.
2 results.
2.1 vaginal symptoms improve situations: after medication 3d, matched group 27.08%(13/48) patient, and soak group and all case pruritus of vagina of powder group, drying, pain symptom all start the improvement that obtains in various degree.Gynecologial examination vaginal wall elasticity increases, and fold is deepened, and pale, the flushing in surface and bleeding are clearly better.According to vaginal health standards of grading, vaginal health scoring is the summation of elasticity, wettability, pH, mucosa, secretions 5 project score values.Before soak group patient medication, scoring is 9.29 ± 2.36, and average of marking after medication 7d is 14.27 ± 2.82.Before powder group patient medication, scoring is 10.62 ± 2.72, and average of marking after medication 7d is 17.27 ± 2.28.Compare before and after medication, after two groups of patient treatments, vaginal health scoring is all obviously increased (P<0.05).
2.2 3 groups of Comprehensive Clinical comparitive study: after medication 7d, matched group cure rate, obvious effective rate, effective percentage, inefficiency are respectively 31.25%, 43.75%, 18.75%, 6.25%; The cure rate of soak group, obvious effective rate, effective percentage, inefficiency are respectively 56.00%, 34.00%, 10.00%, 0.00%; The cure rate of powder group, obvious effective rate, effective percentage, inefficiency are respectively 70.00%, 18.00%, 12.00%, 0.00%.Three groups are compared, and the cure rate of soak group and powder group, total effective rate are apparently higher than matched group (P<0.05), and the cure rate of powder group is apparently higher than soak group (P<0.05).
2.3 adverse reaction rates: three groups of patients all do not occur obvious adverse reaction.
3. conclusion.
This result of study shows, and soak group of the present invention and powder group treatment postpartum perineum mucosa infection total effective rate are 100%, and the cure rate of powder group is higher than soak group.Have the advantage that untoward reaction is comparatively light, safety is higher.

Claims (4)

1. treat the preparation method of postpartum perineum mucosa infection drug powder for one kind, it is characterized in that, crude drug comprises: Cortex erythrinae 20 parts, Herba Chlorophyti Laxi 10 parts, go back 6 parts, bobbin, Alpinia japonica (Thunb.) Miq. 10 parts, Herba Taxilli 6 parts, Radix Ranunculi Ternati 10 parts, Fructus Hordei Germinatus (parched to brown) 10 parts, Massa Medicata Fermentata (parched to brown) 10 parts, Radix Ephedrae 10 parts, Spina Gleditsiae 2 parts, gumshiraz 6 parts, Rhizoma Anemones Altaicae 20 parts, and its preparation method is made up of following steps:
(1) by Cortex erythrinae, Radix Ranunculi Ternati, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Alpinia japonica (Thunb.) Miq., Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Spina Gleditsiae, gumshiraz, Rhizoma Anemones Altaicae and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, pulverizes to obtain dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
2. a kind of preparation method for the treatment of postpartum perineum mucosa infection drug powder according to claim 1, is characterized in that: the pressure of the distilling under reduced pressure in described step (1) is 0.1Mpa.
3. a kind of preparation method for the treatment of postpartum perineum mucosa infection drug powder according to claim 1, is characterized in that: the pressure that the decompression in described step (2) decocts is 0.4Mpa.
4. a kind of preparation method for the treatment of postpartum perineum mucosa infection drug powder according to claim 1, is characterized in that: the pressure of the concentrating under reduced pressure in described step (4) is 0.4Mpa.
CN201310267854.1A 2013-07-01 2013-07-01 Preparation method of powder of medicine for treating postnatal perineum mucosal lesion Expired - Fee Related CN103316270B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310267854.1A CN103316270B (en) 2013-07-01 2013-07-01 Preparation method of powder of medicine for treating postnatal perineum mucosal lesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310267854.1A CN103316270B (en) 2013-07-01 2013-07-01 Preparation method of powder of medicine for treating postnatal perineum mucosal lesion

Publications (2)

Publication Number Publication Date
CN103316270A CN103316270A (en) 2013-09-25
CN103316270B true CN103316270B (en) 2015-03-18

Family

ID=49185503

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310267854.1A Expired - Fee Related CN103316270B (en) 2013-07-01 2013-07-01 Preparation method of powder of medicine for treating postnatal perineum mucosal lesion

Country Status (1)

Country Link
CN (1) CN103316270B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796760A (en) * 2016-05-31 2016-07-27 王海霞 Preparation method of post-episiotomy external medicine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1768829A (en) * 2004-11-05 2006-05-10 郭连英 Chinese medicine for treating tuberculosis
CN102920810A (en) * 2012-11-20 2013-02-13 汉仲月 Mucosa nursing matter for behcet's syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148205C (en) * 2001-01-10 2004-05-05 刘从清 Yinkang lotion
CN103301353B (en) * 2013-07-01 2015-03-11 刘晓晖 Pharmaceutical composition for treating atrophic vaginitis
CN103356932B (en) * 2013-07-01 2015-08-26 陈玉 A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN103301374B (en) * 2013-07-01 2015-02-11 巩春梅 Pharmaceutical composition for treating postpartum non-specificity vaginitis
CN103301373B (en) * 2013-07-01 2015-04-08 朱月英 Pharmaceutical composition for treating postpartum perineal mucosal lesions
CN103285284B (en) * 2013-07-01 2015-04-29 王梅 Medical composition for treating senile vaginitis
CN103330896B (en) * 2013-07-01 2015-05-13 徐静 Preparation method of powder for treating postpartum nonspecific vaginitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1768829A (en) * 2004-11-05 2006-05-10 郭连英 Chinese medicine for treating tuberculosis
CN102920810A (en) * 2012-11-20 2013-02-13 汉仲月 Mucosa nursing matter for behcet's syndrome

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796760A (en) * 2016-05-31 2016-07-27 王海霞 Preparation method of post-episiotomy external medicine

Also Published As

Publication number Publication date
CN103316270A (en) 2013-09-25

Similar Documents

Publication Publication Date Title
CN103520572B (en) A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof
CN102836409B (en) Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method
CN103341092B (en) Preparation method of powder for treating atrophic vaginitis
CN103301353B (en) Pharmaceutical composition for treating atrophic vaginitis
CN103285284B (en) Medical composition for treating senile vaginitis
CN103356932B (en) A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia
CN103301373B (en) Pharmaceutical composition for treating postpartum perineal mucosal lesions
CN103330867B (en) Preparation method of powder for treating senile vaginitis
CN103316270B (en) Preparation method of powder of medicine for treating postnatal perineum mucosal lesion
CN103285300B (en) Medicinal composition for treating stress incontinence
CN105233078A (en) Traditional Chinese medicine composition for treating viral hepatitis
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN103330896B (en) Preparation method of powder for treating postpartum nonspecific vaginitis
CN103301374B (en) Pharmaceutical composition for treating postpartum non-specificity vaginitis
CN103341094B (en) Preparation method of powder for treating vulva squamous epithelial cell hyperplasia
CN103191399A (en) Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period
CN103041194B (en) Traditional Chinese medicine composition for curing chronic eczema and preparation method thereof
CN105125964A (en) Traditional Chinese medicine preparation for treating pelvic peritonitis and preparation method thereof
CN105267895A (en) Medicine for treating bovine postpartum blood stasis type placenta retension and preparing method thereof
CN103301354B (en) Preparation method of powder for treating infantile vaginitis
CN103316258B (en) Medicine composition for treating infantile vaginitis
CN103285301B (en) Method for preparing umbilicus dressing agent for treating stress incontinence
CN103301375B (en) Preparation method of umbilical sticking agent for treating nocturia of children
CN102228569A (en) Chinese patent medicine for treating psoriasis
CN104707036A (en) Externally applied lotion applicable to vaginitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: DING XIAOYAN FENG TAO GENG HUI TO: DING XIAOYAN JIANG CHUNJIE

ASS Succession or assignment of patent right

Owner name: JIANG CHUNJIE

Effective date: 20150210

CB03 Change of inventor or designer information

Inventor after: Ding Xiaoyan

Inventor after: Jiang Chunjie

Inventor before: Ding Xiaoyan

Inventor before: Feng Tao

Inventor before: Geng Hui

TA01 Transfer of patent application right

Effective date of registration: 20150210

Address after: 255036 Zibo Central Hospital, Shandong, Shandong, China, Zhangdian, No. 54, No.

Applicant after: Ding Xiaoyan

Applicant after: Jiang Chunjie

Address before: 255036 Zibo Central Hospital, Shandong, Shandong, China, Zhangdian, No. 54, No.

Applicant before: Ding Xiaoyan

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150318

Termination date: 20150701

EXPY Termination of patent right or utility model